products

adjuvants

  key ingredients to
  effective vaccines


  benefits of adjuvants

  current vaccine
  challenges


  our solutions

  publications

  key scientists

vaccines

  tb vaccine

  leishmaniasis vaccine

  leprosy vaccine

diagnostics

  tb diagnostics

  leishmania diagnostics

  leprosy diagnostics

  chagas diagnostics

  sales contact

therapeutics

  tb drug discovery

Our Products

We target diseases that kill more than six million people each year. Although these diseases have different etiologies, symptoms, global footprints, and challenges, we have a singular goal for each program: developing diagnostic tests, vaccines, and therapeutic products that save lives and improve health outcomes.

Product Pipeline

Piepline

Adjuvants: Key Ingredients to Effective Vaccines

As part of our vaccine platform, we work on adjuvant development. We have developed multiple adjuvant formulations, and are working with collaborators in various disease areas spanning preclinical studies and clinical trials. more


1616 Eastlake Avenue East, Suite 400, Seattle, Washington 98102 office@idri.org  |  P: (206) 381-0883  |  F: (206) 381-3678 © 1993-2014 Privacy Policy
Infectious Disease Research Institute